tradingkey.logo

Omnicell Inc

OMCL
查看詳細走勢圖
45.300USD
-0.620-1.35%
收盤 12/31, 16:00美東報價延遲15分鐘
2.03B總市值
104.80本益比TTM

Omnicell Inc

45.300
-0.620-1.35%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.35%

5天

-1.05%

1月

+25.42%

6月

+51.35%

今年開始到現在

+1.75%

1年

+1.75%

查看詳細走勢圖

TradingKey Omnicell Inc股票評分

單位: USD 更新時間: 2025-12-30

操作建議

Omnicell Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名9/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價48.17。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Omnicell Inc評分

相關信息

行業排名
9 / 207
全市場排名
56 / 4560
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 8 分析師
買入
評級
48.167
目標均價
+10.60%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Omnicell Inc亮點

亮點風險
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入1.11B美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值106.23,處於3年歷史高位
機構減倉
最新機構持股48.76M股,環比減少13.49%
巴羅·漢利持倉
明星投資者巴羅·漢利持倉,最新持倉100.00股

Omnicell Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Omnicell Inc簡介

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
公司代碼OMCL
公司Omnicell Inc
CEOLipps (Randall A)
網址https://www.omnicell.com/

常見問題

Omnicell Inc(OMCL)的當前股價是多少?

Omnicell Inc(OMCL)的當前股價是 45.300。

Omnicell Inc 的股票代碼是什麼?

Omnicell Inc的股票代碼是OMCL。

Omnicell Inc股票的52週最高點是多少?

Omnicell Inc股票的52週最高點是47.690。

Omnicell Inc股票的52週最低點是多少?

Omnicell Inc股票的52週最低點是22.660。

Omnicell Inc的市值是多少?

Omnicell Inc的市值是2.03B。

Omnicell Inc的淨利潤是多少?

Omnicell Inc的淨利潤為12.53M。

現在Omnicell Inc(OMCL)的股票是買入、持有還是賣出?

根據分析師評級,Omnicell Inc(OMCL)的總體評級為買入,目標價格為48.167。

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是多少

Omnicell Inc(OMCL)股票的每股收益(EPS TTM)是0.432。
KeyAI